Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for DNA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 420.28M
March 31, 2026 443.15M
December 31, 2025 508.59M
September 30, 2025 559.78M
June 30, 2025 612.95M
March 31, 2025 647.43M
December 31, 2024 716.06M
September 30, 2024 797.94M
June 30, 2024 833.07M
March 31, 2024 987.27M
December 31, 2023 1.097B
September 30, 2023 1.253B
Date Value
June 30, 2023 1.504B
March 31, 2023 1.608B
December 31, 2022 1.736B
September 30, 2022 1.435B
June 30, 2022 1.535B
March 31, 2022 1.581B
December 31, 2021 1.505B
September 30, 2021 1.552B
June 30, 2021 1.471B
March 31, 2021 1.578B
December 31, 2020 461.38M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Sotera Health Co. 665.65M
Caris Life Sciences, Inc. 591.73M
BillionToOne, Inc. 536.81M
Quest Diagnostics, Inc. 7.516B
Labcorp Holdings, Inc. 8.607B

Shareholders Equity (Quarterly) Related Metrics